KanCare moves forward before Fed approves it
Despite the fact that the federal government has not approved requests to waive a number regulations that would thwart it, Kansas is moving ahead with its KanCare Medicaid overhaul
Despite the fact that the federal government has not approved requests to waive a number regulations that would thwart it, Kansas is moving ahead with its KanCare Medicaid overhaul.
According to the Associated Press (AP), Gov. Sam Brownback plans to turn Medicaid over to three private, managed-care companies starting Jan. 1 after awarding contracts this summer.
But because the federal government provides a majority of the funding for the state's $2.9 billion-a-year program, it must approve multiple waivers Kansas has requested. The state administration is confident the waivers will be approved because the federal government has approved them for other states. Kansas expects approval in August, but AP quotes a federal spokesman who says there is no formal timetable for making a decision.
Kansas submitted its requests a day before new rules for waiver applications took effect. The new rules require two public hearings, public notifications and a report on public comments before submitting an application.
Go back to the Managed Healthcare Executive eNews newsletter.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Unrealistic Portrayals of Cardiac Arrest in Contemporary Film | ACC 2025
March 31st 2025Cardiac arrests in contemporary film are largely inaccurate when it comes to survival rate and etiology, according to a poster presented today at the American College of Cardiology conference held March 29 to 31 in Chicago.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Positive Results for Tirzepatide in Those With the Cardiovascular-Kidney-Metabolic Triad | ACC 2025
March 31st 2025Results from the SUMMIT trial suggest that tirzepatide is as effective in preventing heart failure events in those with chronic kidney disease as those without it, and there are signals that it has benefits for renal function.
Read More
